Do Not Do Recommendation

 
Patients with tumours of known human epidermal growth factor receptor 2 (HER2) status whose disease recurs should not have a further biopsy just to reassess HER2 status.

Do Not Do Recommendation Details

Recommendation:
Patients with tumours of known human epidermal growth factor receptor 2 (HER2) status whose disease recurs should not have a further biopsy just to reassess HER2 status.
Interventions:
Biopsy

Source guidance details

Guidance:
Advanced breast cancer (update) (CG81)
Published date:
July 2014
Paragraph number:
1.1.7
Page number:
10

View all NICE do not do from this Guidance